FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...
The new rules become binding on November 20, but many drug companies have already been acting within these requirements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback